Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Slides:

Advertisements

Similar presentations

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Advertisements

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo,

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Stenting of femoropopliteal lesions using interwoven nitinol stents

Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Vein harvesting technique for infrainguinal arterial bypass with great saphenous vein and its association with surgical site infection and graft patency

Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Mark G. Davies, MD, PhD, MBA, Wael E. Saad, MD, Jean X

Adjunctive use of the superficial femoral vein for vascular reconstructions Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo,

Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric K. Peden, MD, Imran T

The impact of gender on outcome after infrainguinal arterial reconstructions for peripheral occlusive disease Enzo Ballotta, MD, Mario Gruppo, MD, Renata.

Blake A. Hamby, MD, Daniel E. Ramirez, MD, George E

Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.

Remote endarterectomy: Lessons learned after more than 100 cases

Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: Do the results justify an attempt before bypass grafting? Richard.

Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent Bao-Ngoc Nguyen,

Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease Jean-Baptiste Ricco,

Derek de Grijs, MD, Pedro Teixeira, MD, Steven Katz, MD

Cryopreserved saphenous vein graft in infrainguinal bypass

Christopher J. Smolock, MD, Javier E

Clinical efficacy of concomitant tibial interventions associated with superficial femoral artery interventions in critical limb ischemia Christopher.

The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries Jenny J. Lee, MD,

Open versus endovascular revascularization for chronic mesenteric ischemia: Risk- stratified outcomes Gustavo S. Oderich, MD, Thomas C. Bower, MD, Timothy.

Chetan P. Huded, MD, Philip P. Goodney, MD, Richard J

Optimal conduit choice in the absence of single-segment great saphenous vein for below-knee popliteal bypass James T. McPhee, MD, Neal R. Barshes, MD,

Lesion types and device characteristics that predict distal embolization during percutaneous lower extremity interventions Gautam V. Shrikhande, MD,

Thomas S. Huber, MD, PhD, Michael P. Brown, DO, James M. Seeger, MD, W

A comparison of tibial artery bypass performed with heparin-bonded expanded polytetrafluoroethylene and great saphenous vein to treat critical limb ischemia

W. Anthony Lee, MD, Peter R. Nelson, MD, Scott A

Infrainguinal cutting balloon angioplasty in de novo arterial lesions

Lower extremity arterial reconstruction for critical limb ischemia in diabetes Enzo Ballotta, MD, Antonio Toniato, MD, Giacomo Piatto, MD, Franco Mazzalai,

Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease Christopher J. Smolock, MD, Javier.

Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: Results of primary and secondary procedures Hans Schweiger, MD,

James T. McPhee, MD, Philip P

A personal experience with the influence of diabetes and other factors on the outcome of infrainguinal bypass grafts for occlusive disease Norman R.

Outcomes of renal artery angioplasty and stenting using low-profile systems Brian W. Nolan, MD, Marc L. Schermerhorn, MD, Erin Rowell, MD, Richard J.

Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients Andrew M. Bakken, MD, Clinton D. Protack,

Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched.

Primary stenting of the superficial femoral and popliteal artery

Balloon angioplasty for revision of failing lower extremity bypass grafts Haitham Ali, MD, Ahmed Elbadawy, MD, Mahmoud Saleh, MD, Ayman Hasaballah, MD

Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD

Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial

Wei Zhou, MD, Peter H. Lin, MD, Ruth L. Bush, MD, Eric K

Eric C. Scott, MD, Andre Biuckians, MD, MPH, Ryan E

Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric.

Radiation arteritis: A contraindication to carotid stenting?

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease Hasan H.

Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency Carlos Eduardo Pereira, MD, Maximiano Albers, MD, PhD, Marcello.

Javier G. Jimenez, MD, Thomas S. Huber, MD, PhD, C

Manish Mehta, MD, MPH, Yi Zhou, MD, Philip S. K

The influence of metabolic syndrome on hemodialysis access patency

Use of computer simulation for determining endovascular skill levels in a carotid stenting model Jeffrey H. Hsu, MD, PhD, Duraid Younan, MD, Sudha Pandalai,

Long-term outcomes of patients undergoing endovascular infrainguinal interventions with single-vessel peroneal artery runoff Christopher J. Abularrage,

Outcome after autogenous brachial-basilic upper arm transpositions in the post-National Kidney Foundation Dialysis Outcomes Quality Initiative era Heather.

Christopher L. Skelly, MD, Katherine Gallagher, BS, Ronald M

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty

Efficacious use of nitinol stents in the femoral and popliteal arteries Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD

Femorofemoral bypass with femoral popliteal vein

The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience Toshifumi Kudo, MD, PhD,

Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes William P. Robinson, MD, Louis L.

The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease—Decision analysis Brian Nolan, MD,

Percutaneous transluminal angioplasty and stenting as first-choice treatment in patients with chronic mesenteric ischemia Bram Fioole, MD, PhD, Hendrik.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Iliac artery stenting versus surgical reconstruction for TASC (transatlantic inter-society consensus) type B and type C iliac lesions Carlos H Timaran,

Presentation transcript:

Percutaneous angioplasty and stenting of the superficial femoral artery Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W. Eberly, MS, Jeffrey M. Rhodes, MD, Karl A. Illig, MD, Cynthia K. Shortell, MD, David E. Lee, MD, David L. Waldman, MD, PhD, Richard M. Green, MD Journal of Vascular Surgery Volume 41, Issue 2, Pages 269-278 (February 2005) DOI: 10.1016/j.jvs.2004.11.031 Copyright © 2005 The Society for Vascular Surgery Terms and Conditions

Fig 1 Primary patency of SFA PTA/S (broken down by lesion type) compared with femoropopliteal bypass with prosthetic (asterisks within boxes). Error bars omitted for clarity. All standard errors <10% for data shown. The number of patients at risk at each time interval is shown below the figure. A, TASC A lesion; B, TASC B lesion; C,TASC C lesion; D, TASC D lesion; P, prosthetic femoropopliteal bypass (polytetrafluoroethylene, Dacron). Journal of Vascular Surgery 2005 41, 269-278DOI: (10.1016/j.jvs.2004.11.031) Copyright © 2005 The Society for Vascular Surgery Terms and Conditions

Fig 2 Primary patency of SFA PTA/S (broken down by lesion type) compared with femoropopliteal bypass with vein (asterisks within boxes). Error bars omitted for clarity. All standard errors <10% for data shown. The number of patients at risk at each time interval is shown below the figure. A, TASC A lesion; B, TASC B lesion; C, TASC C lesion; D, TASC D lesion; V, femoropopliteal bypass with autogenous vein. Journal of Vascular Surgery 2005 41, 269-278DOI: (10.1016/j.jvs.2004.11.031) Copyright © 2005 The Society for Vascular Surgery Terms and Conditions

Fig 3 Kaplan-Meier analysis showing freedom from recurrent symptoms after PTA/S of the SFA. Patients with TASC A and B lesions are compared to patients with TASC C and D lesions. Error bars indicate standard errors. The number of patients at risk at each time interval are shown in the table below the figure. The difference between the two groups was statistically significant. Journal of Vascular Surgery 2005 41, 269-278DOI: (10.1016/j.jvs.2004.11.031) Copyright © 2005 The Society for Vascular Surgery Terms and Conditions